Drug & Medication Database

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Pancreas/stomach Drops 5021

11. DESCRIPTION Pancrelipase is a pancreatic enzyme product consisting of a mixture of enzymes including lipases, proteases, and amylases, and is an extract derived from porcine pancreatic glands. VIOKACE (pancrelipase) tablets are for oral administration and available as follows: 10,440 USP units of lipase; 39,150 USP units of protease; and 39,150 USP units of amylase as a tan, round biconvex tablet and have VIO9111 engraved on one side and 9111 on the other side.

Brands: Viokace

Manufactured by ORGANON USA INC. Dosage form: CAPSULE. Route: ORAL. Active ingredients: PANCRELIPASE (AMYLASE (30,000USP UNITS); LIPASE (8,000USP UNITS); PROTEASE) (30,000USP UNITS). Application: BLA020580.

Dosage form: CAPSULE, DELAYED RELEASE PELLETS. Active ingredients: PANCRELIPASE AMYLASE (15000 [USP'U]/1); PANCRELIPASE LIPASE (3000 [USP'U]/1); PANCRELIPASE PROTEASE (9500 [USP'U]/1). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION Pancrelipase is a pancreatic enzyme product consisting of a mixture of enzymes including lipases, proteases, and amylases and is an extract derived from porcine pancreatic glands. The enteric-coated microtablets in PANCREAZE are formulated to release pancreatic enzymes at an approximate pH of 5.5 or greater.

Brands: Pancreaze

11 DESCRIPTION Pancrelipase is a pancreatic enzyme product consisting of a mixture of enzymes including lipases, proteases, and amylases, and is an extract derived from porcine pancreatic glands. The enteric-coated pellets in ZENPEP are formulated to release pancreatic enzymes at an approximate pH of 5.5 or greater. ZENPEP (pancrelipase) delayed-release capsule for oral administration, include a two-piece shell containing light brown-colored enteric-coated pellets (1 .

Brands: Zenpep

Dosage form: CAPSULE, DELAYED RELEASE. Active ingredients: PANCRELIPASE AMYLASE (252600 [USP'U]/1); PANCRELIPASE LIPASE (60000 [USP'U]/1); PANCRELIPASE PROTEASE (189600 [USP'U]/1). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: CAPSULE, DELAYED RELEASE. Active ingredients: PANCRELIPASE AMYLASE (14000 [USP'U]/1); PANCRELIPASE LIPASE (3000 [USP'U]/1); PANCRELIPASE PROTEASE (10000 [USP'U]/1). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: POWDER. Active ingredients: PANCURONIUM BROMIDE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: PANCURONIUM BROMIDE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Panitumumab is an epidermal growth factor receptor (EGFR) antagonist for intravenous use. Panitumumab is a human IgG2 kappa monoclonal antibody with an approximate molecular weight of 147 kDa that is produced in genetically engineered mammalian (Chinese hamster ovary) cells.

Brands: Vectibix

Dosage form: POWDER. Active ingredients: PANOBINOSTAT LACTATE (1 kg/kg). Category: BULK INGREDIENT.

skin protect

Brands: Reorganic Eyelash Growth Boosting Serum

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets, USP, a PPI, is a substituted benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl] sulfinyl]benzimidazole, sodium salt, sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S . 1.5 H 2 O, with a molecular weight of 432.4. The structural formula is: Pantoprazole sodium sesquihydrate, USP is a white to off-white powder.

Brands: Pantoprazole Sodium

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE MAGNESIUM (25 kg/25kg). Category: BULK INGREDIENT.

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets USP, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl] -1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.4.

Brands: Pantoprazole Sodium

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.37. The structural formula is: Pantoprazole sodium is a white to off-white powder and is racemic.

Brands: Pantoprazole Sodium Delayed-release

The active ingredient in Pantoprazole Sodium Delayed-Release Tablets, USP, a PPI, is a substituted benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl] sulfinyl]benzimidazole, sodium salt, sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16H 14F 2N 3NaO 4S . 1.5 H 2O, with a molecular weight of 432.4. The structural formula is: Pantoprazole sodium sesquihydrate, USP is a white to off-white powder.

Brands: Pantoprazole Sodium Dr

11 DESCRIPTION The active ingredient in pantoprazole sodium for delayed-release oral suspension, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.37.

Brands: Pantoprazole Sodium Delayed-release Delayed Release

11 DESCRIPTION The active ingredient in pantoprazole sodium in 0.9% sodium chloride injection, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C16H14F2N3NaO4S, with a molecular weight of 405.4. The structural formula is: Pantoprazole sodium is a white to off-white crystalline powder and is racemic.

Brands: Pantoprazole Sodium

11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The structural formula is: Pantoprazole sodium is a white or almost white powder and is racemic.

Brands: Pantoprazole Sodium

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE SODIUM (50 kg/50kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE SODIUM (50 kg/50kg). Category: BULK INGREDIENT.

Manufactured by HOSPIRA. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: ASCORBIC ACID (N/A,80MG/VIAL); BIOTIN (N/A,0.02MG/VIAL); CYANOCOBALAMIN (N/A,0.001MG/VIAL); ERGOCALCIFEROL (400 IU/10ML,N/A); FOLIC ACID (N/A,0.14MG/VIAL); NIACINAMIDE (N/A,17MG/VIAL); PANTOTHENIC ACID (N/A,5MG/VIAL); PHYTONADIONE (0.2MG/10ML,N/A); PYRIDOXINE (N/A,1MG/VIAL); RIBOFLAVIN (N/A,1.4MG/VIAL); THIAMINE (N/A,1.2MG/VIAL); VITAMIN A PALMITATE (EQ 2,300 UNITS BASE/10ML,N/A); VITAMIN E (7 IU/10ML,N/A). A

Dosage form: POWDER. Active ingredients: PAPAVERINE HYDROCHLORIDE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

DESCRIPTION Papaverine Hydrochloride, USP, is the hydrochloride of an alkaloid obtained from opium or prepared synthetically. It belongs to the benzylisoquinoline group of alkaloids. It does not contain a phenanthrene group as do morphine and codeine. Papaverine Hydrochloride, USP, is 6,7-dimethoxy-1- veratrylisoquinoline hydrochloride and contains, on the dried basis, not less than 98.5% of C 20 H 21 NO 4 •HCl. The molecular weight is 375.85. The structural formula is as shown.

Brands: Papaverine Hydrochloride

For Facial Skin Moisturizing, Antioxidant, Blemish Removal, Whitening, Brightening

Brands: Papaya Gluta Facecream

For skin cleansing, exfoliation，Nourish and Whitening

Brands: Papaya Glutasoap

For relief of sinus congestion and rhinitis. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.

Brands: Ricura

Dosage form: POWDER. Active ingredients: AMINOHIPPURIC ACID (1 kg/kg). Category: BULK INGREDIENT.